Domain-interface dynamics of CFTR revealed by stabilizing nanobodies
The leading cause of cystic fibrosis is the deletion of phenylalanine 508 (F508del) in the first nucleotide-binding domain (NBD1) of the cystic fibrosis transmembrane conductance regulator (CFTR). Here authors we develop nanobodies targeting NBD1 of human CFTR and demonstrate their ability to stabil...
Guardado en:
Autores principales: | Maud Sigoillot, Marie Overtus, Magdalena Grodecka, Daniel Scholl, Abel Garcia-Pino, Toon Laeremans, Lihua He, Els Pardon, Ellen Hildebrandt, Ina Urbatsch, Jan Steyaert, John R. Riordan, Cedric Govaerts |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a36a5cc137946bdbc014d5d58e302cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanobody-enabled monitoring of kappa opioid receptor states
por: Tao Che, et al.
Publicado: (2020) -
Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor
por: Sahil Gulati, et al.
Publicado: (2018) -
Evaluation of antidiphtheria toxin nanobodies
por: Ghada H Shaker
Publicado: (2010) -
Association of the CFTR gene with asthma and airway mucus hypersecretion.
por: Astrid Crespo-Lessmann, et al.
Publicado: (2021) -
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Xun Chen, et al.
Publicado: (2021)